首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1532486

球囊瓣膜成形術設備市場- 按產品類型（標準、切割、評分球囊）、應用（主動脈瓣狹窄、肺動脈瓣狹窄）、年齡層（兒科、成人）、最終用途（醫院、ASC） - 全球預測（2024 年 -第2032章

Balloon Valvuloplasty Devices Market - By Product Type (Standard, Cutting, Scoring Balloon), Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), Age Group (Pediatric, Adult), End-use (Hospitals, ASCs) - Global Forecast (2024 - 2032)

出版日期: 2024年05月17日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於醫療保健支出的增加和醫療保健基礎設施的進步，預計 2024 年至 2032 年全球球囊瓣膜成形術設備市場規模的複合年成長率將達到 4.8%。根據美國醫學會的數據，2022 年美國醫療保健支出成長 4.1%，達到 4.5 兆美元，即人均 13,493 美元。這一成長支持了對先進治療的更大投資，以改善心臟護理。

最近，由於醫療保健支出不斷增加，大量資源被分配用於創新治療，包括球囊瓣膜成形術。醫療保健設施的擴大和增強正在改善先進手術的取得。此外，對醫療基礎設施的投資不斷增加，支持了球囊瓣膜成形術設備的廣泛使用，使其在治療心臟瓣膜疾病方面更容易、更有效。

球囊瓣膜成形術設備市場按產品類型、應用、年齡層、最終用途和地區分類。

按產品類型分類，由於治療狹窄心臟瓣膜的需求不斷增加，切割球囊細分市場預計從 2024 年到 2032 年將以顯著速度成長。與傳統手術方法相比，這些設備提供了侵入性較小的選擇，在改善心臟護理方面取得了重大進展。此外，配備鋒利刀片的切割球囊可透過在瓣膜組織中進行精確切口，有助於擴大瓣膜並恢復正常血流，在治療狹窄方面發揮重要作用。

由於為心臟病患者提供專門護理的需求不斷成長，預計門診手術中心最終用途部分的球囊瓣膜成形術設備行業將在 2024 年至 2032 年期間成長。這些中心使用球囊瓣膜成形術裝置來治療心臟瓣膜狹窄的患者。該技術可進行微創手術，以改善患者的治療效果並縮短復原時間。透過將這些設備整合到他們的服務中，門診手術中心確保他們處於心臟護理的最前沿，為患者提供更安全、更有效的治療選擇。

從地區來看，在人口老化和心血管手術擴張的推動下，歐洲球囊瓣膜成形術設備產業規模預計將在 2024 年至 2032 年間強勁成長。該地區的醫療保健提供者正在採用這些設備來更有效地管理心臟瓣膜狀況。隨後，醫療技術的快速進步以及透過提高精確度和護理來解決人口老化的複雜性的程序數量的增加將推動該產品在整個歐洲的普及。

產業生態系統分析
產業影響力
- 成長動力
  - 瓣膜性心臟病盛行率增加
  - 老年人口不斷增加
  - 科技不斷進步
- 產業陷阱與挑戰
  - 球囊瓣膜成形術的局限性
  - 併發症的風險
成長潛力分析
技術景觀
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
標準氣球
切割氣球
計分氣球
高壓氣球
低壓氣球

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
主動脈瓣狹窄
肺動脈瓣狹窄

第 7 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
兒科
成人

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
專科診所
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson, and Company
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical Inc.
Edwards Lifesciences Corporation
Innomed Medical Development Ltd.
Jotech GmbH
Medtronic plc
Microport Scientific Corporation
Numed Canada Inc.
NuMED Inc.
Osypka Medical GmbH
Teleflex Incorporated

簡介目錄

Product Code: 9540

Global Balloon Valvuloplasty Devices Market size is predicted to record 4.8% CAGR from 2024 to 2032, due to the rising healthcare expenditure and advancements in healthcare infrastructure. According to the American Medical Association, the healthcare spending in the U.S. increased by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rise is supporting greater investment in advanced treatments for improved cardiac care.

Of late, significant resources are being allocated towards innovative treatments, including balloon valvuloplasty on account of the increasing healthcare expenditure. The expansion and enhancement of healthcare facilities are improving access to advanced procedures. In addition, the increasing investments in healthcare infrastructure is supporting the widespread use of balloon valvuloplasty devices, making them more accessible and effective in treating heart valve conditions.

The balloon valvuloplasty devices market is segregated into product type, application, age group, end-use, and region.

By product type, the cutting balloons segment is estimated to grow at a significant rate from 2024 to 2032, due to increasing demand to treat narrowed heart valves. These devices are making significant strides in improving cardiac care by offering a less invasive option compared to traditional surgical methods. Moreover, cutting balloons equipped with sharp blades have a prominent role in treating stenosis by making precise incisions in the valve's tissue which helps in widening the valve and restoring normal blood flow.

Balloon valvuloplasty devices industry from the ambulatory surgical centers end-use segment is expected to rise from 2024 to 2032, fueled by the increasing need for providing specialized care for patients with heart conditions. Balloon valvuloplasty devices are used in these centers to treat patients with narrowed heart valves. This technique allows minimally invasive procedures for improving patient outcomes and recovery times. By integrating these devices into their services, ambulatory surgical centers are ensuring that they are at the forefront of cardiac care for offering patients safer and more effective treatment options.

Regionally, the Europe balloon valvuloplasty devices industry size is anticipated to depict robust growth between 2024 and 2032, propelled by the aging population and the expansion of cardiovascular procedures. Healthcare providers in the region are adopting these devices to manage heart valve conditions more effectively. Subsequently, the rapid advancements in medical technology and the higher volume of procedures to address the complexities of the aging population with enhanced precision and care will drive the product uptake across Europe.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of valvular heart disease
  - 3.2.1.2 Rising geriatric population
  - 3.2.1.3 Growing technological advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Limitations of balloon valvuloplasty
  - 3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Standard balloon
5.3 Cutting balloon
5.4 Scoring balloon
5.5 High-pressure balloon
5.6 Low-pressure balloon

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Aortic valve stenosis
6.3 Pulmonary valve stenosis

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pediatric
7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centres
8.4 Specialty clinics
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa